tada ... makes sense, especially when you consider apabetalone is the first molecule within a vast library of molecules, and accumulated science & knowledge. We aren't talking about just one blockbuster, but also potentially several decades of dominance in a vast unmet market, and leadership and dominance position in a a potentially medicine-altering new frontier.

In the hands of an experienced and well-resourced BP, there is plenty of room for vision & imagination, reality, and the future. 

Anything within "hand grenade" range of your thoughts would be pleasing. A few days ago I would have "settled" for $1b and 4x (ish) ROI on my investment (a super good ROI in reality) ... today, not so much. I like the way you are thinking.